ACCESSION: MSBNK-SMB_Measured-HSA015P0338004
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 11
COMMENT: RAW_SPEC {'EL22_pos_10580': {'bp': 37538.0, 'sum': 379723.0}, 'EL08_pos_10455': {'bp': 32361.0, 'sum': 325137.0}, 'Blanc2-pos_10390': {'bp': 29950.0, 'sum': 258531.0}, 'EL20_pos_10461': {'bp': 29191.0, 'sum': 322326.0}, 'EL19_pos_10366': {'bp': 24922.0, 'sum': 219579.0}, 'EL14_pos_10355': {'bp': 23791.0, 'sum': 219013.0}, 'EL15_pos_10378': {'bp': 23310.0, 'sum': 253509.0}, 'Blanc3-pos_10288': {'bp': 22514.0, 'sum': 213465.0}, 'EL24_pos_10313': {'bp': 22104.0, 'sum': 209932.0}, 'EL06_pos_10312': {'bp': 22020.0, 'sum': 219883.0}, 'Blanc3-pos_10229': {'bp': 21925.0, 'sum': 187487.0}}
COMMENT: RETENTION_TIME_STDEV 0.129
COMMENT: PRECURSOR_M/Z_RAW 338.341703
COMMENT: PRECURSOR_M/Z_STDEV 0.000148
COMMENT: PRECURSOR_IN_MS1 mz 338.341689; int 42.310; delta(ppm) 1.237578
COMMENT: PROPOSED_CHARGE_STATE +1; mz 339.345123; int 10.070; cor 0.818
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+IsoProp+H; M+CH3OH+H; mz 310.310259; int 3.151; cor 0.673
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.166; C22H43NO; [M+H]+; delta(ppm) -0.166007
COMMENT: PROPOSED_MF SevenGoldenRules 2.899; C16H44N5P; [M+H]+; delta(ppm) 2.899200
COMMENT: PROPOSED_MF SevenGoldenRules 2.182; C19H35N; [M+IsoProp+H]+; delta(ppm) -2.181939
COMMENT: PROPOSED_MF MS-FINDER 3.340; C22H43NO; [M+H]+; delta(ppm) -0.166793
COMMENT: PROPOSED_MF MS-FINDER 3.027; C19H35N; [M+IsoProp+H]+; delta(ppm) 94043.483786
COMMENT: PROPOSED_MF SIRIUS5_Sirius 19.674; C22H43NO; [M+H]+; delta(ppm) -0.166793
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C22H43NO; [M+H]+; delta(ppm) -0.166793
COMMENT: PROPOSED_MF SIRIUS6_Sirius 36.037; C22H43NO; [M+H]+; delta(ppm) -0.166793
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.440; C20H41N4; [M+H]+; delta(ppm) 3.801587
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C22H43NO; [M+H]+; delta(ppm) -0.166793
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.159; VMFXYTSKMWPHQH-UHFFFAOYSA-N; [M+H]+; O=C(NCCCCCCCCCCCCCCC)C1CCCCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.040; UAUDZVJPLUQNMU-UHFFFAOYSA-N; [M+H]+; CCCCCCCCC=CCCCCCCCCCCCC(O)=N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.933; COUPDYRANTUKKV-MSUUIHNZSA-N; [M+H]+; CCCCCCCCCCCCCCC\C=C/CCCCC(N)=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.596; UAUDZVJPLUQNMU-UHFFFAOYSA-N; [M+H]+; docos-13-enamide, Amides, C22 (unsaturated)
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.414; COUPDYRANTUKKV-MSUUIHNZSA-N; [M+H]+; 6-cis-Docosenamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.379; CYXKNKQEMFBLER-UHFFFAOYSA-N; [M+IsoProp+H]+; Perhexiline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.369; VMFXYTSKMWPHQH-UHFFFAOYSA-N; [M+H]+; N-pentadecylcyclohexanecarboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.166; NNAFMHTUNBLVDA-TWYLJJHKNA-N; [M+IsoProp+H]+; UNPD126188
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.166; OATZINGONWAXGM-LGWFVXIRNA-N; [M+IsoProp+H]+; UNPD175952
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.081; YCQNSAJAZIVRFR-QINVSXPYNA-N; [M+IsoProp+H]+; UNPD195804
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.008; GBAJOZSDDXKZJQ-UHFFFAOYSA-N; [M+IsoProp+H]+; 1-(2,2,5,9-tetramethyldeca-4,8-dien-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.989; NJYPILZTMPWERT-PTWZPDMYNA-N; [M+IsoProp+H]+; UNPD184359
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; UAUDZVJPLUQNMU-UHFFFAOYSA-N; [M+H]+; docos-13-enamide, Amides, C22 (unsaturated)
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.978; COUPDYRANTUKKV-MSUUIHNZSA-N; [M+H]+; 6-cis-Docosenamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.929; VMFXYTSKMWPHQH-UHFFFAOYSA-N; [M+H]+; N-pentadecylcyclohexanecarboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 4.000; UAUDZVJPLUQNMU-KTKRTIGZSA-N; [M+H]+; (Z)-docos-13-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.653; NVSOSXIRJQBCAP-UHFFFAOYSA-N; [M+H]+; 2-heptadecyl-4,4-dimethyl-5H-1,3-oxazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -25.878; WLUWZVUXQSJMCW; [M+H]+; N-Butyloleamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -30.062; UAUDZVJPLUQNMU; [M+H]+; Erucylamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -59.970; ANBZTKMYPDMODS; [M+H]+; N,N-diethyloctadec-9-enamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -65.432; COUPDYRANTUKKV; [M+H]+; 6-cis-docosenamidse
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -77.710; VMFXYTSKMWPHQH; [M+H]+; N-Pentadecylcyclohexanecarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -94.050; AEBDOCOLSSICMC; [M+H]+; Pyrrolidine, 1-stearoyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -141.281; OSNVKHBQAYVRFA; [M+H]+; 4-octadec-9-enylmorpholine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.270; WLUWZVUXQSJMCW; [M+H]+; N-Butyloleamide
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C22H44N1O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 16.925
MS$FOCUSED_ION: PRECURSOR_M/Z 338.341685
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0aps-9203000000-855e5cbf844ee518cabb
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0545032 527.5693 55.055211 0.6176 73.43 0.5879 10 f{C4H7}/5.02ppm,p-C18H37N1O1
  57.0701399 526.3360 57.070856 0.3855 72.14 0.7000 11 f{C4H9}/4.61ppm,p-C18H35N1O1
  67.0543649 267.3072 67.055106 1.1036 43.73 0.5364 11 f{C5H7}/2.06ppm,p-C17H37N1O1
  69.0700379 666.4176 69.070781 0.6081 75.63 0.7636 11 f{C5H9}/2.33ppm,p-C17H35N1O1
  71.0856204 254.8161 71.086364 0.8018 39.21 0.6727 11 f{C5H11}/1.32ppm,p-C17H33N1O1
  79.0542067 133.5677 79.054939 1.3535 32.72 0.6333 9 f{C6H7}/-0.25ppm,p-C16H37N1O1
  81.0698909 417.7841 81.070617 1.0608 42.13 0.7545 11 f{C6H9}/0.18ppm,p-C16H35N1O1
  83.0855961 510.0243 83.086315 0.8425 51.20 0.8364 11 f{C6H11}/0.83ppm,p-C16H33N1O1
  93.0698083 182.0404 93.070475 1.8266 38.30 0.4788 10 f{C7H9}/-0.73ppm,p-C15H35N1O1
  95.0855503 426.4999 95.086203 0.9465 39.52 0.7182 11 f{C7H11}/0.25ppm,p-C15H33N1O1
  97.1011095 372.2195 97.101746 1.4521 92.17 0.5818 11 f{C7H13}/-0.69ppm,p-C15H31N1O1
  100.0755414 131.4274 100.076153 1.0692 20.51 0.6167 9 f{C5H10N1O1}/-1.49ppm,p-C17H34
  107.0854457 157.6213 107.085988 1.0459 37.27 0.5030 10 f{C8H11}/-0.76ppm,p-C14H33N1O1
  109.1012292 233.8133 109.101758 0.8891 34.19 0.2833 9 f{C8H13}/0.48ppm,p-C14H31N1O1
  111.0802532 119.2949 111.080767 1.3414 28.98 0.3333 8 f{C7H11O1}/-1.69ppm,p-C15H33N1
  111.1168659 172.9859 111.117380 1.6649 35.80 0.4667 10 f{C8H15}/0.35ppm,p-C14H29N1O1
  114.0913252 133.8581 114.091816 1.6040 25.12 0.7857 8 f{C6H12N1O1}/-0.13ppm,p-C16H32
  121.1010978 170.9463 121.101527 1.0652 34.63 0.6333 9 f{C9H13}/-0.65ppm,p-C13H31N1O1
  303.3036022 267.3511 303.304014 0.9364 22.36 0.8909 11 f{C22H39}/-3.38ppm,p-H5N1O1
  321.3140493 328.9346 321.314473 1.3787 50.77 0.4286 8 f{C22H41O1}/-3.56ppm,p-H3N1
  338.3414915 999.0000 338.341925 1.0404 0.00 1.0000 11 f{C22H44N1O1}/-0.74ppm,p
PK$NUM_PEAK: 21
PK$PEAK: m/z int. rel.int.
  55.054503 527.57 527
  57.070140 526.34 526
  67.054365 267.31 267
  69.070038 666.42 666
  71.085620 254.82 254
  79.054207 133.57 133
  81.069891 417.78 417
  83.085596 510.02 510
  93.069808 182.04 182
  95.085550 426.50 426
  97.101109 372.22 372
  100.075541 131.43 131
  107.085446 157.62 157
  109.101229 233.81 233
  111.080253 119.29 119
  111.116866 172.99 172
  114.091325 133.86 133
  121.101098 170.95 170
  303.303602 267.35 267
  321.314049 328.93 328
  338.341491 999.00 999
//
